Australian scientists have found a potential cure for hepatitis B virus (HBV) infections, with a promising new treatment proving 100 per cent successful in eliminating the infection in preclinical models.
Australian patients are now the first in the world to have access to the potential treatment – a combination of an antiviral drug and an anti-cancer drug – which is in phase 1/2a clinical trials in Melbourne, Perth and Adelaide.
Scientists from Melbourne’s Walter and Eliza Hall Institute developed the combination treatment using birinapant, a drug developed by US biotech company TetraLogic Pharmaceuticals for treating cancer. Hepatitis B is a chronic viral disease that is currently incurable.
READ FULL ARTICLE From Au